FindTrial
Sign In

Use of CRP/albumin ratio in predicting severity of acute pancreatitis

Role of CRP/albumin ratio in acute pancreatitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/01/030806
Enrollment
62
Registered
2021-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K859- Acute pancreatitis, unspecified

Interventions

None listed

Sponsors

Kasturba medical college Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed with acute pancreatitis.

Exclusion criteria

Exclusion criteria: 1) Pregnancy 2) Patients with chronic liver disease 3) Recurrent/chronic pancreatitis

Design outcomes

Primary

MeasureTime frame
Reliability of CRP/albumin ratio in predicting the severity, morbidity and mortality in acute pancreatitisTimepoint: 10 days—

Secondary

MeasureTime frame
Efficacy of crp/albumin ratio in predicting prognosis of acute pancreatitis compared to routinely used other investigationsTimepoint: 10 days—

Countries

India

Contacts

Public ContactDr Kshama S Hegde

Department of general surgery, Kasturba medical college, Manipal

prasad.ss@manipal.edu8105468373

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026